Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 3/20 | 0.31 |
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | CA9 | Q16790 | 3/20 | 0.31 |
| ▸ | PYGB | P11216 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24996778 | 1.00 | MAPK1 (0.32) | MAPK1LMNAKMT2APOLBALDH1A1 | |
| SCHEMBL7150321 | 0.82 | LMNA (0.40) | MAPK1LMNAKMT2APOLBALDH1A1 | |
| SCHEMBL16392993 | 0.81 | MAPK1 (0.33) | MAPK1LMNAKMT2APOLBALDH1A1 | |
| SCHEMBL12280200 | 0.75 | MAPK1 (0.46) | MAPK1LMNAKMT2AALDH1A1THRB | |
| SCHEMBL22559700 | 0.75 | LMNA (0.55) | LMNAKMT2APOLBALDH1A1CA12 | |
| SCHEMBL7155174 | 0.74 | LGALS3 (0.44) | MAPK1ALDH1A1CA1CA2CA9 | |
| SCHEMBL7154489 | 0.74 | LGALS3 (0.44) | MAPK1ALDH1A1CA1CA2CA9 | |
| SCHEMBL24996759 | 0.72 | AMDHD2 (0.31) | — | |
| SCHEMBL7150319 | 0.71 | LGALS3 (0.41) | MAPK1ALDH1A1CA1CA2CA9 | |
| SCHEMBL16393012 | 0.71 | LMNA (0.35) | LMNAKMT2APOLBALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023011597-A1 | LIGAND CONJUGATES FOR DELIVERY OF THERAPEUTICALLY ACTIVE AGENTS | Hepagene Therapeutics (HK) Limited (CN) | 2023-02-09 | — | — | WO | disclosed |